Business Context and Reporting Period
This Form 8-K Current Report was filed by Penumbra, Inc. on May 27, 2020, regarding a material definitive agreement entered into on that date. The report details a public offering of common stock executed on June 1, 2020.
Key Financial Metrics
- Capital Raised: The Company issued and sold an aggregate of 865,963 shares of Common Stock.
- Net Proceeds: Approximately $135.1 million, after deducting underwriting discounts and commissions but before estimated offering expenses.
- Offering Structure: Included the full exercise of the underwriters' option to purchase an additional 112,951 shares.
- Underwriters: J.P. Morgan Securities LLC and BofA Securities, Inc. acted as representatives.
Material Changes
The primary material change is the increase in equity capital and cash liquidity resulting from the public offering. The filing does not provide comparative financial data (revenue, profit, or margins) for prior periods as this is a transaction-specific report rather than a periodic financial statement.
Guidance, Outlook, and Use of Proceeds
Management intends to use the net proceeds for general corporate purposes, specifically:
- Working capital.
- Continued product development, including research and development and clinical trials.
- Potential acquisitions and other business opportunities.
Pending deployment, the Company plans to invest the proceeds in investment-grade, interest-bearing securities. The filing notes that certain underwriters or their affiliates provide commercial banking services and are lenders under the Company's existing credit agreement.
Investor Verification Checklist
- Verify the final closing date and total share count (865,963 shares) against the June 1, 2020 transaction records.
- Confirm the exact net proceeds received after all offering expenses are finalized.
- Review the Underwriting Agreement (Exhibit 1.1) for lock-up periods or specific covenants.
- Monitor future filings for the specific allocation of funds toward R&D, clinical trials, or acquisitions.